Verastem to Present at Rodman & Renshaw 18th Annual Global Investment Conference
September 06 2016 - 7:00AM
Business Wire
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and
developing drugs to treat cancer, today announced that the company
will present at the Rodman & Renshaw 18th Annual Global
Investment Conference on Tuesday, September 13th at 10:25 AM
Eastern Time at The Lotte New York Palace Hotel.
A live audio webcast of the presentation will be available on
the company’s website at www.verastem.com. An archived presentation
will be available for 90 days.
About Verastem, Inc.
Verastem, Inc. (NASDAQ:VSTM) is a biopharmaceutical company
focused on discovering and developing drugs to improve outcomes for
patients with cancer. Our product candidates utilize a
multi-faceted approach to treat cancer by reducing cancer stem
cells, enhancing anti-tumor immunity, and modulating the local
tumor microenvironment. Our most advanced clinical product
candidates are the Focal Adhesion Kinase inhibitors, VS-6063 and
VS-4718, and the dual PI3K/mTOR inhibitor, VS-5584. For more
information, please visit www.verastem.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160906005306/en/
Verastem, Inc.Brian Sullivan,
781-292-4214bsullivan@verastem.com
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Apr 2023 to Apr 2024